With respect to the numerous ways that p53 mutants operate to alter the tumor cell secretome, one may therefore differentiate between mechanisms that are caused by the abrogation or inhibition of wild-type p53 functions (loss-of-function and dominant-negative activities) or true neomorphic mutant p53 activities (Figure 1). Here, TP53 is linked to neoplasm.